Codeine-Containing Cough Medications: Prescription Guidelines
Codeine phosphate with guaifenesin is the primary codeine-containing cough medication, dosed at 10mg codeine/100mg guaifenesin per 5mL, and should be prescribed only for short-term relief of dry cough due to minor throat and bronchial irritation when non-opioid options have failed. 1
First-Line Approaches Before Codeine
Before prescribing codeine-containing products, consider these evidence-based alternatives:
Non-pharmacological approaches:
Non-opioid medications:
When to Consider Codeine
Codeine should be reserved for:
- Persistent dry cough not responding to first-line treatments
- Cough due to chronic bronchitis (where it has demonstrated 40-60% reduction in cough counts) 3
- Nocturnal cough disrupting sleep 3
Prescription Details for Codeine-Containing Products
When prescribing codeine for cough:
- Standard formulation: Codeine phosphate 10mg with guaifenesin 100mg per 5mL 1
- Dosing: Typically 5-10mL every 4-6 hours as needed
- Duration: Limited to short-term use (3-7 days)
- Schedule: Classified as a controlled substance requiring appropriate prescription protocols
- Maximum daily dose: Generally not to exceed 120mg of codeine per day
Important Prescribing Considerations
Efficacy Considerations
- Codeine is effective for cough due to chronic bronchitis but has limited efficacy for cough due to upper respiratory infections 3
- Consider that codeine must be metabolized to morphine by CYP2D6 to be effective, and efficacy varies based on patient metabolism 4
Safety Precautions
- Contraindications: Avoid in patients with respiratory depression, MAOI use, head injury
- Drug interactions: Caution with CNS depressants, antihistamines, and CYP2D6 inhibitors
- Side effects: Monitor for drowsiness, constipation, nausea, and respiratory depression 4
- Dependency risk: Limit duration of use due to potential for physical dependence 4
Special Populations
- Elderly: Use lower doses due to increased sensitivity to side effects
- Pregnancy: Avoid if possible, especially in third trimester 2
- Children: Not recommended due to safety concerns and limited evidence of efficacy
Alternative Opioid Antitussives
If codeine is not suitable, consider:
- Hydrocodone (5mg twice daily) 2
- Dihydrocodeine (10mg three times daily) 2
- Pholcodine (where available) 3
Monitoring and Follow-up
- Assess response after 2-4 days 2
- Discontinue if no improvement is observed
- Ensure adequate expectoration despite cough suppression 2
- Watch for red flags requiring immediate attention (hemoptysis, increasing breathlessness, fever)
Common Pitfalls to Avoid
- Prescribing codeine for viral URI cough where efficacy is limited 3
- Extended use beyond 7-10 days, increasing dependency risk
- Failure to consider CYP2D6 metabolism variations affecting efficacy
- Not recognizing that combination products may contain other active ingredients with their own side effects
- Overlooking non-opioid alternatives that may be equally effective with fewer side effects 5